Making Stem Cells

Compatible

with Everyone

Embryoid bodies, fluorescent light micrograph

Editing Stem Cells to Cure Disease

3D rendering of recombinant Adeno-Associated Virus

rAAV

Universal Cells creates Universal Donor Stem Cells by editing the genes required for immune recognition. By using our recombinant Adeno-Associated Virus (rAAV) technology, we design and manufacture stem cell-based products that can be used as off-the-shelf cell therapies.

Our Technology

One Universal Stem Cell Bank

rAAV

Universal Donor Cells are pluripotent and can differentiate into various cell types that can be used to treat a vast number of diseases. Learn more about the Universal Cells’ pipeline and partnerships.

Pipeline

Latest News

Seattle Channel profiles Astellas’ Universal Cells employee competing in the 2018 Special Olympics USA Games

July 18th, 2018|0 Comments

For the past several months, 21-year-old Devon Adelman has served as an ambassador for Special Olympics, and she won a gold medal in the 2018 Special Olympics USA Games in stand up paddleboard. “As an [...]

Astellas Acquires Universal Cells, Inc.

February 14th, 2018|1 Comment

Acquisition enables Astellas to fully utilize proprietary technology to produce pluripotent stem cells that have the potential to lower immunological rejection in numerous therapeutic areas Tokyo, February 13, 2018 - Astellas Pharma Inc. (TSE: 4503, [...]

Astellas and Universal Cells, Inc. Announce a Collaboration Utilizing Universal Donor Cell Technology

October 20th, 2017|0 Comments

Tokyo, October 19, 2017 - Astellas Pharma Inc. (TSE: 4503, President and CEO: Yoshihiko Hatanaka, “Astellas”) and Universal Cells, Inc. (CEO: Claudia Mitchell, “Universal Cells”) today announced that Astellas Institute for Regenerative Medicine (“AIRM”) and [...]